A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma.

  • Garcia, Alex V. Mejia (CoI)

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/18 → 1/1/25

Funding

  • Genmab